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Abstract
Background: Myosin heavy chain 7 (MYH7)-related myopathies are emerging as an important group of muscle
diseases of childhood and adulthood, with variable clinical and histopathological expression depending on the type
and location of the mutation. Mutations in the head and neck domains are a well-established cause of hypertrophic
cardiomyopathy whereas mutation in the distal regions have been associated with a range of skeletal myopathies
with or without cardiac involvement, including Laing distal myopathy and Myosin storage myopathy. Recently the
spectrum of clinical phenotypes associated with mutations in MYH7 has increased, blurring this scheme and adding
further phenotypes to the list. A broader disease spectrum could lead to misdiagnosis of different congenital
myopathies, neurogenic atrophy and other neuromuscular conditions.
Results: As a result of a multicenter Italian study we collected clinical, histopathological and imaging data from a
population of 21 cases from 15 families, carrying reported or novel mutations in MYH7. Patients displayed a variable
phenotype including atypical pictures, as dropped head and bent spine, which cannot be classified in previously
described groups. Half of the patients showed congenital or early infantile weakness with predominant distal
weakness. Conversely, patients with later onset present prevalent proximal weakness. Seven patients were also
affected by cardiomyopathy mostly in the form of non-compacted left ventricle. Muscle biopsy was consistent with
minicores myopathy in numerous cases. Muscle MRI was meaningful in delineating a shared pattern of selective
involvement of tibialis anterior muscles, with relative sparing of quadriceps.
Conclusion: This work adds to the genotype-phenotype correlation of MYH7-relatedmyopathies confirming the
complexity of the disorder.
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Background
The MYH7 gene on chromosome 14 encodes slow/b-
cardiac myosin heavy chain (MyHCI), a class II myosin
expressed in slow, type 1 muscle fibers as well as in the
heart ventricles. MyHCI is the molecular motor of
muscle and forms the backbone of the sarcomere thick
filaments [1].
As expected both cardiac and skeletal muscle disorders
can arise from a defect of MYH7. MYH7- related cardiac
diseases are more frequent and include familial hyper-
trophic/dilated cardiomyopathy (MIM 192600), and left
ventricular non-compaction (LVNC) cardiomyopathy
(MIM 613426) with more than 200 mutations described
so far [2].
Skeletal myopathies due to MYH7 mutations were
initially classified in two main subgroups according to
clinical and pathological findings: myosin storage
myopathy (MSM, MIM 608358) and Laing distal
myopathy (LDM, MIM 160500). Additional pheno-
types have been reported over the years, including a
scapulo-peroneal or limb-girdle muscle form with or
without morphological features of myosin storage [3],
multi-minicore disease with variable cardiac involve-
ment [4, 5] and families with morphological features
suggestive of congenital fiber type disproportion [6, 7].
These disorders are either due to de novo mutations or
inherited in a dominant fashion although cases with
autosomal recessive inheritance have seldom been re-
ported [8, 9].
Slow/b-cardiac myosin in vivo exists as a dimer of two
globular heads attached to a long, α-helical coiled-coil
region. The N-terminus heads bind actin and ATP,
which is required for motor activities. The C-terminus
rod assembles myosin into thick filaments of the sarco-
mere through charge-based interactions between adja-
cent rods [10]. Mutations accounting for the cardiac or
skeletal muscle disorders cluster in different parts of the
protein: most cardiomyopathy related mutations are lo-
cated in the globular head domain potentially affecting
the binding sites for actin [2] whereas those linked to
skeletal myopathy are usually located in the distal re-
gions of the rod domain (also called light meromyosin
domain -LMM). In particular, mutations that cause my-
osin storage myopathy (MSM) affect the very distal end
of the tail, (exons 37–40) whereas most but not all pa-
tients reported with LDM display mutations in exons
32-36 in the mid region of MYH7 [11]. However, there is
a greater than expected overlap of phenotypes as cases
with both heart and muscular manifestations are
described.
Here we report clinical, morphological, and myoima-
ging data from 21 patients with confirmed mutations in
MYH7 to better characterize the emerging genotype–
phenotype correlation in these myopathies.
Methods
Patients were recruited from a multicenter study on
congenital myopathies which gathered 13 Italian tertiary
care centers for pediatric and adult neuromuscular dis-
orders. Written informed consent was obtained from all
subjects or their legal guardians when primary diagnos-
tic procedures were performed, with explicit consent for
future use for research purposes and publication of
images. All patients underwent a systematic clinical
characterization by at least two experts in neuromuscu-
lar disorders, including neurological, cardiac (ECG and
echocardiogram), and respiratory (spirometer) assess-
ments. CK level was recorder in all patients. Follow up
ranged from 5 to 30 years. Neurophysiological studies
(EMG and nerve conduction velocity) were performed
in 12 patients.
In 9 cases the presence of suggestive clinical and histo-
pathological signs directly targeted the Sanger sequen-
cing of the coding regions of MYH7. Twelve cases were
diagnosed as unspecific myopathies and, in absence of
disease markers, underwent Motorplex analysis, a tar-
geted molecular tool in next-generation sequencing
(NGS) designed to analyze 93 genes known to be re-
sponsible of different inherited myopathies [12].
The experimental strategies, variants annotation and
prioritization in Motorplex were as described elsewhere
[13]. In particular, we used different prediction algo-
rithms such as PolyPhen, SIFT e Mutation Taster to cor-
roborate the causative effect of novel variants identified.
To predict the splicing effect of splice-site variants, we
consulted http://www.fruitfly.org/seq_tools/splice.html.
All the mutations identified in MYH7 were confirmed
by Sanger sequencing. Segregation analysis was per-
formed using DNA from all available family members.
RNA from the skeletal muscle biopsies in patients 6
and 19 was extracted using TRIzol reagent according to
the manufacturer’s instructions (Invitrogen, Carlsbad,
CA, USA). Messenger RNA was retrotranscribed using
the SuperScript III kit (Invitrogen). For the cDNA
analysis, the following primers were used: 36_37F: 5'-
AAGGCCATCACGGATGCC; 3'UTR_R: 5'-CCTCAAG
GGCGGCAAGAA.
Having reached a confirmatory molecular diagnosis,
we reviewed the muscle histology features in 16 patients
adopting standard histological and histochemical stains.
In four patients, we also performed immunohistochemi-
cal analyses to study the expression of slow MyHC
(NCL-MHCs Novocastra Lyophilized Mouse Monoclonal
Antibody).
Muscle MRI was performed in 14 patients according
to conventional protocol examining axial planes of the
pelvis and lower limbs with T1-weighted spin echo se-
quences. All muscle MRI imaging data were reviewed
and scored by two experts (EM, GT) in the network.
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In silico prediction of the effect of novel mutations
falling in the LMM region was performed using the
COILS program [14], a web-based tool which compares
a specific amino acidic sequence to a database of already
known parallel two-stranded coiled-coils. By using a
similarity score, COILS is able to calculate the probabil-
ity of a coiled-coil conformation. In particular, a MTIDK
matrix derived from myosins, paramyosins, tropomyo-
sins, intermediate filaments type I - V, desmosomal
proteins and kinesins scanning windows of 14, 21 and
28 amino acidic residues was used to calculate the
probability of coiled coil formation for the wt sequence
and 4 selected missense mutations in the LMM domain.
Results
Patients
Twenty-one patients are described. Twelve are women
and nine men. Age varied between 7 and 70 years. Age
at onset was between 0 and 49 years. Age at diagnosis
was between 6 and 68 years. Nine cases were sporadic,
nine displayed positive family history (Fig. 1) whereas in
two further cases a positive family history was reported
Fig. 1 Pedigrees of the familial cases
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but possibly affected relatives were not available for clin-
ical examination nor for genetic analysis. Another pa-
tient (case 8) had two mutations, one inherited from the
asymptomatic mother (Family 4).
Clinical presentation
Detailed clinical data of patients are summarized in
Table 1. Five patients presented onset at birth or in the
first year of life, four patients had onset during child-
hood, whereas most patients (9/21) had adult onset of
the muscle weakness (>18 years), though in a single case
arched palate had been reported since infancy (case 21).
One patient (case 12) aged 7 years, was affected only by
cardiomyopathy without muscle weakness. Heart impair-
ment was revealed only by a positive family history
(Family 3). Weakness of distal muscle was shared by all
the patients, except case 7 who displayed only weakness
of neck flexor when examined at age 8. Nine patients
had only distal leg involvement with tibialis anterior
weakness. Toe dropping was one of the first sign
recalled at onset for seven patients (Table 1). In eight pa-
tients hands weakness was also present and this was the
predominant feature in five cases, however this was not
present at onset. Wrist extensor and fourth- fifth fingers
extensor muscles (ulnar side) were particularly affected,
whereas thumb abduction and second finger extension
were less involved, giving a peculiar sign of pointed sec-
ond finger (Fig. 2c-d). In nine cases there was also prox-
imal muscle weakness. Axial weakness was a common
finding present in 11 cases and nine patients had scoli-
osis, whereas two presented rigid spine. Foot deformities
were noticed in nine cases, two had club foot since in-
fancy, whereas seven patients developed pes cavum and
hammertoe later with the disease progression. Facial
weakness was variably present with ptosis (three cases)
and elongated face (two cases). Disease can be severe
(5/21) and was usually progressive over time, however
most patients were still ambulant at time of diagnosis.
Two patients displayed respiratory involvement and
required mechanical non-invasive ventilation from age
7 and 16 years. Two more patients had mild respira-
tory dysfunction restrictive type with FVC reduction
since late teen.
Heart was affected in seven cases (all men), and
ranged from bundle branch block to overt cardiomy-
opathy with features of non-compaction of left ven-
tricle. Two patients required a pace-maker. Another
case (case 5) suffered from episodes of pericarditis.
Serum CK levels were normal or mildly elevated
(below 1500 U/l) in all patients. EMG was usually
myopathic, however three patients (cases 8, 14, and 21)
presented also neurogenic features such as polyphasic and
increased amplitude motor potentials and two (cases 8
and 14) had been diagnosed with a motor neuropathy for
several years before genetic studies allowed the correct
diagnosis.
Atypical features
Case 4 is an 8-year-old boy who came to medical atten-
tion at the age of 4 for dropped head due to isolated
weakness of neck extensors (Fig. 2b). Muscle biopsy dis-
played several minicores (Fig. 3 a-b). Molecular analysis
of SEPN1 and LMNA was performed and mutations ex-
cluded. Follow up evaluation at age 8 revealed also
hypertrophy of gastrocnemii and heart ultrasound dis-
covered signs of left ventricular non compaction. This
together with the presence of calves hypertrophy and the
absence of rigid spine could have better targeted the
genetic investigation.
Case 8 is a 35-year-old man with longstanding diagno-
sis of motor neuropathy predominantly affecting the
lower limbs. This patient developed in his 20s a progres-
sive weakness of axial muscle ending in a bent spine
phenotype (Fig. 2e). Interestingly he carried two muta-
tions in MYH7, one inherited from his 70-year-old
mother who is clinically normal (Fig. 1 Family 4). Thus,
in patient 8 we cannot totally rule out an AR pattern of
inheritance.
Case 12 is a 7-year-old boy, the son of case 10 in
family 3. He presented with only elevated serum CK
when the father received a molecular diagnosis.
Further investigations revealed signs of LVNC cardio-
myopathy but neurological examination is normal.
Genetic analyses confirmed that he carried the same
mutation in MYH7.
Cases 15 and 18 have an unremarkable family history
and share a similar clinical phenotype characterized by
early onset congenital myopathy and marked respiratory
muscles involvement requiring pulmonary support. Case
18 also has arched palate. Both patients showed normal
serum CK levels and a prevalent weakness in the axial
muscle with scoliosis. The patients carry different muta-
tions localized in the same LMM domain
Familial variability
Nine patients belong to three different families present-
ing an autosomal dominant pattern of transmission.
Family pedigrees are in Fig. 1.
Family 1 comprises two affected siblings, one 70-year-
old man (case 1) and one 64-year-old woman (case 2)
and the 35-year-old daughter of case 1. All family mem-
bers share a similar phenotype characterised by late
onset distal myopathy mainly affecting lower limbs with
subsequent involvement of proximal limbs in the two
eldest patients. In no case there was respiratory involve-
ment; however case 1 also displays hypertrophic cardio-
myopathy. Muscle biopsy displayed hypotrophy of type 1
fibres and presence of cores like area.
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Table 1 Clinical, histopathological and genetic features
# Age Family
history
Onset of symptoms Weakness distribution Scoliosis Respiratory
involvement
Cardiac involvement CK U/l EMG Muscle biopsy Mutation
1 M 70 yes adult proximal and distal
lower limb
no no CMH 944 myopathic cores c.4303 T > C p.Ser1435Pro
TA weakness
2 F 64 yes adult axial, proximal and
distal lower limb
yes no no normal myopathic cores c.4303 T > C p.Ser1435Pro
TA weakness
3 F 36 yes adult distal lower limb no no no normal myopathic na c.4303 T > C p.Ser1435Pro
4 M 22 no childhood axial, distal upper and
lower limbs
rigid spine yes recurrent pericarditis 711 na minicores c.4850_4852del p.Lys1617del
TA weakness mild restrictive
from age 16
5 F 48 yes childhood distal upper and
lower limbs
yes no no normal na minicores c.4807G > C p.Ala1603Pro
TA weakness
6 F 16 yes congenital axial, distal upper and
lower limbs
yes no no normal na na c.4807G > C p.Ala1603Pro
7 M 8 no congenital axial yes no LVNC normal myopathic minicores c.5655 + 1G > A p.1854_1885del
8 M 35 noa childhood axial and distal yes no no 720 myopathic and
neurogenic
cores c.4850_4852del p.Lys1617del
c.4855G > A p.Glu1619Lys
TA weakness
9 M 68 yes adult axial proximal distal yes no LVNC and PM 400-500 myopathic FTD c.5401G > A, p.Glu1801Lys
10 M 40 yes adult proximal and distal
lower limb
no no LVNC and PM 400-500 myopathic FTD c.5401G > A, p.Glu1801Lys
11 M 38 yes adult proximal and distal
lower limb
no no LVNC 400-500 na na c.5401G > A, p.Glu1801Lys
12 M 7 yes no muscle symptom normal no no LVNC 1400 na na c.5401G > A, p.Glu1801Lys
13 F 59 yes adult proximal and distal
lower limb
rigid spine no no normal myopathic cores c.4315G > C p.Ala1439Pro
proximal onset
14 F 58 no adult proximal upper and
lower limb
na no no 450 myopathic and
neurogenic
unspecific c.4363G > T, p.Glu1455X
15 F 20 no childhood axial and distal
lower limb
yes yes no normal na unspecific c.4475 T > C p.Leu1492Pro
NIV needed
from age 17
16 F 39 no adult axial proximal distal no no no normal myopathic na c.1780C > A p.Leu594Met
hands onset
17 M 36 no childhood axial and distal upper
and lower limb
no no no normal na unspecific c.5779A > T, p.Ile1927Phe
18 F 18 no congenital axial and distal
lower limb
yes (severe) yes left bunlde block normal myopathic unspecific c.5655G > A, p.Ala1885Ala
NIV needed
from age 7
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Table 1 Clinical, histopathological and genetic features (Continued)
19 F 33 yes childhood proximal and distal
upper and lower limb
yes yes no normal myopathic minicores c.4850_4852del, p.Lys1617del
TA weakness mild restrictive
from age 25
20 F 39 no adult distal axial and proximal no no no normal myopathic cores c.5808G > C, p.X1936Tyr
21 F 40 no adult distal no no no 500 myopathic hyalin bodies c.1322C > T p.Thr441Met
TA weakness
FTD fibre type disproportion, NIV non invasive ventilation, LVNC left ventricular non compaction, PM pace-maker, CMH cardiomyopathy hypertrophic. a case 8 reported negative family history albeit his mother actually
carries one mutation of MYH7 but shows no symptoms of myopathy nor cardiac disease
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Family 2 consists of a 48-year-old woman (case 5) and
her 16-year-old daughter (case 6). An elder sister of case
5 and her 93-year-old mother were reportedly affected
by a severe scoliosis and tetraparesis with loss of ambu-
lation; they were not available for our clinical examina-
tions. Case 5 has seven unaffected siblings and shows an
early onset distal myopathy with typical bilateral hand
involvement. Her daughter, case 6, has mainly axial and
distal myopathy. Interestingly, face weakness and scoli-
osis were also prominent in this family, whereas there
were no pulmonary or heart involvements. Muscle bi-
opsy performed only in the mother showed marked uni-
formity of fibre type and presence of diffuse mini-cores.
Family 3 has previously been described elsewhere by
same authors [7]. Briefly, this is a three-generation fam-
ily with four affected men and a frequent cardiac in-
volvement and mild-to-moderate weakness in distal
upper and lower limbs which worsened with age. Two
patients required permanent pacemaker. As for other
relatives, an additional patient (case 12) with non com-
pacted left ventricle was recently detected in this family.
This boy had initially escaped molecular testing because
he was asymptomatic at the time of our first report. A
subsequent ECG recording prompted MYH7 testing and
heart ultrasound revealed the presence of non com-
pacted left ventricle. Neurological investigation is cur-
rently normal at the age of 7 years.
In Family 4, case 8 harbors the c.4855G > A/
p.Glu1619Lys on the maternal allele in compound het-
erozygosity with c.4850_4852del p.Lys1617del. Parents
are reportedly healthy, though the father had died before
our studies because of a cancer. Although the missense
variant affecting residue 1619 has already been associ-
ated with familial dilated cardiomyopathy [15] and it
appears to modify myosin protein structure upon studies
in silico with COILS, we cannot firmly established that
this variant is pathogenic and cannot conclude on the
pattern of transmission in this patient.
Histopathology
Muscle sections were available for revision in 16 cases
(Additional file 1: Table S2). Cores and mini-cores were
found in nine patients. Other common findings included
centrally located nuclei (eight cases) and type 1 predom-
inance (in four) or fibre type disproportion (FTD) in
three patients (in two families), defined by percentage of
Fig. 2 Clinical images from selected cases. a: case 4 at 16 years old presenting a distal phenotype with weakness and atrophy of upper limbs
whereas shoulder girdle is normal. Note mild ptosis and calf hypertrophy. b: case 7 at 5 years of age. Strength is preserved except in axial muscle
with dropped head. Mild ptosis is also present. The boy was also diagnosed with non-compacted left ventricle. c and d: two pictures of hands
weakness (case 5 and 8) particularly affecting third, fourth and fifth fingers whereas second and first finger are spared. As consequence, patients
have difficulties in raising the ulnar part of the hand. In (e) the bent appearance of the spine in patients 8. Note also the severe distal atrophy of
lower limbs for which the patient had a diagnosis of motor neuropathy
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type 1 fibre greater that 80 % and average diameter of
type 1 fibre smaller than type 2 fibre of 30 %. In three
further muscles biopsies a selective hypotrophy of type 1
fibres was detected. We also observed that connective
tissue could be increased, especially if the biopsy is taken
at later stage of the disease. Case 4 underwent two
consecutives muscle biopsies: the first at 7 years old
showed significant cores and minicores (Additional file 2:
Figure S8), whereas the second biopsy at 15 years taken
from the contralateral muscle, cores were no longer evi-
dent (Fig. 3g-i). Hyaline bodies which are typical of MSM
were looked for and encountered only in case 21 (Fig. 3d),
whereas case 5 presented a single rimmed vacuole in a
minicore myopathy muscle biopsy. Of note both patients
performed biopsy in adulthood.
Myosin staining with specific antibodies was also per-
formed in four patients (case 4,5,7,and 8) to test for
myofibrillar alteration and demonstrated a normal ex-
pression of slow myosin in myofilaments.
Muscle MRI
Pelvis, thigh and lower leg T1w images were reassessed
in 13 of 20 patients in whom myoimaging had been per-
formed (Fig. 4, Additional file 3: Table S3 and Additional
file 4: Figure S9).
All the patients showed tibilias anterior as the most af-
fected muscle followed by extensor digitorium longus,
with relative sparing of the peroneal group. This was in-
dependent from age at muscle MRI. Gastrocnemii were
involved in about half of the patients with a slight pre-
dominance of the medial gastrocnemius.
Muscle MRI of the thigh showed prevalent antero-
medial involvement with vastus medialis, adductor mag-
nus and sartorius affected in one third of patients; vastus
Fig. 3 Muscle biopsy spectrum. a and b: Case 7: NADH and COX stainings, respectively showing presence of mutiple cores (magnification 20x).
c: Case 8: COX staining of muscle sections showing severe alteration of intermyofibrillar network such as moth eaten fibres (magnification 40x).
d: Case 21: NADH staining displaying hyaline bodies (magnification 40x). e: Case 10. This case has already been described in reference Ruggiero
et al. NADH staining presenting fibre type disproportion with small type 1 fibres representing the majority of fibres and larger type 2 fibres
(magnification 10x). f: Case 8. ATP 9.6 (magnification 10x) reveals pronounced type 1 predominancy or nearly uniformity. Most fibres are type 1
with only few scattered type 2 fibres. g-l: Case 4 had two muscle biopsies taken at different ages. In the first biopsy at age 7 years, COX (g) and
NADH (h) staining showed clear cores in numerous fibres. The same staining (i and l) did not show cores, however the inter-myofibrillar network
appeared diffusely pale and thin in the second biopsy performed ten years later
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intermedius, semimembranosus and biceps femoris were
also affected, at a lesser extent. Rectus femoris was usu-
ally spared with the only exception of case 16, 17 and 21
where there was complete substitution of all the thigh
muscles.
Molecular analyses
We identified 14 heterozygous mutations in MYH7.
Most were missense affecting the C-terminal rod do-
main between exons 31-39 (LMM domain). Two mis-
sense mutations are located in exons 14 and 16 thus
affecting the NH domains. Additional file 5: Table S4
summarizes the mutations identified in this study
whereas Fig. 5 depicts how they are distributed along
the presumed protein structure.
Novel mutations
Four novel mutations, including two missense, a change
affecting the splice site junction and a variant affecting
the stop codon (stop loss) were identified.
In particular, a novel change in exon 31 (c.4303 T > C,
p.Ser1435Pro) was detected in Family 1. Patient 6
showed a novel c.5655 + 1G > A variant leading to an in-
frame skipping of exon 38 (Additional file 6: Figure S7).
A novel stoploss mutation (c.5808G > C/p.X1936Tyr)
was identified in patient 14. The variant is predicted to
determine the addition of 31 extra amino acids to the
encoded protein (p.X1936YfsX32). Lastly, patient 16
showed an unreported missense variant (c.1780C > A
p.Leu594Met). The variant, affecting an amino acid con-
served during the evolution, is not reported in public da-
tabases collecting NGS data (ExAC, 1000Genomes or
Exome Variant Server) and all the in silico tools used for
its interpretation (SIFT, Polyphen, Mutation Taster) pre-
dicted a putative damaging effect. Even if a segregation
analysis is hampered by the lack of further relatives, we
considered the variant probably causative of the pheno-
type observed in patient 16.
Previously described mutations
We identified ten already described mutations. In the
affected members of family 2 (case 5-6) and in pa-
tients 13 and 15, we identified already described
changes to Proline [16, 17]. A different missense vari-
ant (c.5401G > A/p.Glu1801Lys) segregating with the
disease was identified in members of Family 3, as re-
ported [7].
Two missense mutations (c.5779A > T/p.Ile1927Phe
and c.1322C > T/p.Thr441Met) were identified in pa-
tients 17 and 21. These variants have previously been as-
sociated with cardiomyopathy [18–20] a clinical feature
not detected in our two patients. A similar scenario oc-
curs for the nonsense c.4363G > T/p.Glu1455*, already
reported elsewhere [21].
The recurrent p.Lys1617del [17] was found in three
different patients (case 4, 8 and 19). A de novo syn-
onymous mutation c.5655G > A/p.Ala1885Ala was
identified in patient 18. The variant, very recently de-
scribed by Pajusalu [22], causes an in-frame skipping
of exon 38 (Additional file 6: Figure S7). Conse-
quently, the encoded protein is predicted to be 32
amino acids shorter than the wild type. Both the
c.5655G >A and the c.5655 + 1G >A mutations (identified
in patients 18 and 7, respectively) cause an identical effect
on the protein sequence (p.1854_1885del).
Functional analysis of mutations of the LMM domain
We performed functional prediction studies using the
COILS program of the following mutations: p.Ser1435-
Pro, p.Ala1439Pro, p.Ala1603Pro and p.Glu1619Lys.
All mutations affect the ability of the protein to form
stable and functional thick filament, changing the shape
Fig. 4 Muscle MRI of lower limb of three cases with different severity. Upper images refer to thigh, whereas lower images refer to calf muscles.
Case 7 in (a) is the less affected and only initial fat substitution of tibialis anterior is noted. This feature is shared by all the patients. Interesting, in
this case only, the tibialis involvement seems to start from the periphery of the muscle, a feature which has been already described in quadriceps
muscles of COL6 mutated patients. In (b) involvement of medial gastrocnemius and very initial involvement of vastus medialis is present. This MRI
belongs to case 6 at age 16. In (c) the tibialis anterior is totally replaced by fat tissue. Medial and lateral gastrocnemii are also affected. In the
thight, vastus medialis and adductor magnus are involved but rectus femori is spared. This is case 5 and MRI was performed at 44 years of age
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of the heptad repeat motif in the LMM region.
(Additional file 7: Figure S6)
Discussion
MYH7 mutations often lead to a distal myopathy starting
at lower limb
To date 327 mutations in MYH7 have been reported in
the related mutation database, myoMAPR (http://
bmf2.colorado.edu/myomapr/) and it has becoming clear
that alterations in MYH7 are no longer an uncommon
cause of skeletal myopathy. The forms of MSM and
LDM are fronting a growing number of isolated or fa-
milial cases, which do not exhibit distal muscle weakness
or do not have hyaline bodies nor other myofibrillar
alteration in muscle biopsy [4, 5]. In their place, mini-
cores and core myopathy or features of FTD have
been commonly reported. Recently Lamont and col-
leagues described well this broadened spectrum of
MYH7-related myopathies reporting findings in fam-
ilies with known and novel mutations in MYH7 [23].
Our data largely matches Lamont work in that the
LDM form is definitely more common than MSM,
being present here as the predominant phenotype in
19 of 21 patients. However since onset can be in
adult and in childhood we preferred here to use the
general term distal myopathy (DM). Similar to the
Australian multicenter study, we found that axial in-
volvement is common (42 %) and can seldom be the
prime feature presenting with bent spine and dropped
head as in cases 7 and 8. Also, we observed that the
distal myopathy usually starts in the lower limbs lead-
ing to foot deformities.
MYH7 cardiomyopathy is common in male and can be
also due to mutations in tail regions
Whilst clinical presentation of MYH7 skeletal myopathy
is starting to be better clarified, more complexity arises
with the concomitant presence of cardiomyopathy. It
was initially postulated that mutations in the NH globu-
lar head mainly led to a cardiomyopathy phenotype,
whereas mutations in the COOH tail domain, in particu-
lar the LMM domain, were responsible for the skeletal
myopathies variably associated with cardiomyopathy.
This distinction is no longer pertinent as several cases
with skeletal myopathies and mutations in the globular
head have been reported [24], usually presenting
Fig. 5 Morbidity map. Schematic representation of the MYH7 protein with its domain and distribution of the mutations described in the study.
Most mutations are localized in the C-terminus of the protein. Near each mutation, phenotype is briefly described. DM distal myopathy; CMP
cardiomyopathy; CM congenital myopathy; LGMD limb girdle muscular dystrophy; FTD fibre type disproportion
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associated cardiac involvement [18, 25]. On the other
hand, several reports of cardiomyopathy and muta-
tions in the tail COOH domain of the protein have
also been described [7, 9, 23]. In our cohort, cardio-
myopathy occurred in seven cases and uniquely asso-
ciated with tail domain mutations. Conversely, the
only two patients who harbored mutations in the
globular head did not manifest heart disease. Of note,
clinically relevant cardiomyopathy is common in men
from our study group and this does not seem to cor-
relate with the age at disease manifestations. Factors
associated with male hormone might be hypothesized
to play a role, whereas genetic modifiers associated
with X-chromosome are ruled out by the occurrence
of a male-to-male transmission in fewer families (see
also Fig. 1- Family 3). On the other hand, several mu-
tations previously reported associated with cardiomy-
opathy are not causing cardiac manifestation in our
patients. If these data point to the difficulties in
phenotype-genotype correlations, little is usually re-
ported on the neurological and neuromuscular exami-
nations of patients described with a predominant
heart involvement and we cannot exclude the pres-
ence of subtle features affecting skeletal muscles.
MYH7 cases have interfamilial variability and less
intra-familial variability
Several previous reports describe familial variability in
MYH7-related myopathy [3, 26, 27]. Conversely, in our
study, we observed rather homogeneous phenotype,
albeit this of course cannot be applied to later onset
forms, where younger patients present only a part of the
full clinical spectrum. There are two reports of recessive
form of MYH7 related myopathies [8, 9]. In both studies,
patients carry homozygous mutations and display a
scapulo-peroneal myosin storage phenotype associated
with cardiomyopathy. We have not identified any reces-
sive family; however, case 8 in our study carries two
different heterozygous mutations leaving open the possi-
bility of an AR inheritance.
In our cohort, the most severely affected patients
(case 15 and 18) have early onset with diffuse
muscle weakness and wasting, progressive scoliosis
and respiratory involvement very much resembling
congenital myopathies without cardiac involvement.
At the opposite spectrum, three patients (case 1, 9,
13) have mainly distal weakness with onset in later
adulthood similar to most common neuropathies.
Two of these patients presented cores in muscle bi-
opsy, whereas the third has features of FTD and se-
vere cardiac involvement (case 9). A milder and
mainly proximal weakness is also described in a 60-
year-old patient (case 14) with unspecific changes at
muscle biopsy.
MYH7 myopathy often shows progression of symptoms
and later cardiac involvement
All patients presented in this study have a progressive
course of the disease sometimes with proximal in-
volvement in later stages as suggested also by Lamont
[23]. Certainly a proximal weakness is common in
older patients of our cohort, whereas congenital or
childhood cases usually manifest a typical atrophy of
the anterior lower leg compartment and hypertrophy
of posterior leg. Moreover, cardiac manifestations usu-
ally affect adult population or develop after the skel-
etal myopathy. Case 12 represents the exception to
this rule; he presented at the age of 7 years only with
initial signs of LVNC cardiomyopathy and elevated
CK, without overt muscle weakness. His father and
grandfather (case 9 and 10) had classical LDM, a
more severe cardiomyopathy and required pacemaker
implantation. A similar report has been described in a
five-generation family with a progressive cardiac in-
volvement ranging from relaxation abnormality to
noncompaction, ventricular arrhythmias, and dilated
cardiomyopathy [28].
All these considerations propose a continuum in the
disease spectrum related to MYH7 mutations from early
onset forms with features resembling a congenital myop-
athy to adult forms with also proximal involvement and
heart disease.
Disease progression can be also depicted by evolution
of the muscle histopathology as shown in case 4. In
this patient clear cores and mini-cores lesions were
evident in the first biopsy (Fig. 3 g-l and Additional
file 2: Figure S8). Ten years later, a second biopsy
from the contralateral muscle failed to identify cores
and showed a diffuse alteration of the myofibrillar
network. Modification of muscle damage in congenital
myopathies overtime is not a new concept, being de-
scribed already for cores and nemaline biopsies [29].
Core pathology is common in muscle biopsies from MYH7
mutated cases
Our revision of muscle biopsies from 16 patients showed
that the LDM phenotype is often associated with core
pathology, and FTD is another common histopathology
feature. In general, histological analyses in our cohort
suggest an overlap with the spectrum of congenital my-
opathies as already indicated by description of central
cores in MYH7-related hypertrophic cardiomyopathy
and by several familial reports with FTD [6, 7, 22]. On
the contrary, only one of the muscle biopsies in our
series met the pathological criteria for hyaline bodies/
myosin storage and abnormal expression of slow myosin
in myofilaments was not encountered. This result cannot
be explained with differet genotypes, as most of the pre-
vious mutations associated with hyaline bodies were
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localized in the tail domain of slow myosin [30, 31],
which is the most affected domain also in our study.
Novel mutations and genotype-phenotype correlation in
comparison to literature
Our study also added a second case with the c.5655G >A
variation in exon 38 (case 18) after the case described by
Pajusalu et al [22] and a further de novo splicing mutation
(c.5655 + 1G >A) affecting intron 38 in case 7. In both
cases, as expected, we confirmed an in-frame skipping of
the exon 38 upon mRNA analyses in skeletal muscle Add-
itional file 6: Figure S7). The subsequent lack of 32 amino
acids in the myosin tail (p.1854_1885del) may probably
hamper the correct assembly of the myosin filament as
suggested [21]. Albeit they presented a similar pathobiolo-
gical mechanism, the two patients, showed different phe-
notypes: a dropped head due to axial involvement
together with heart dysfunction in case 7 and an early in-
fantile onset of respiratory muscle impairment in case
18..[22]. Most important in the muscle biopsies of case 7
and 18 there were no features of FTD which characterized
the Estonian boy identified by exome sequencing reported
in [22].
In seven patients (of which three in family 1 and two
in family 2) we identified different missense variants in
the tail LMM domain changing highly conserved amino
acids to proline and likely influencing protein domain
structure, including the novel c.4303 T > C p.Ser1435Pro
(Family 1). Previous works reported that mutations in
the LMM region might affect the ability of the protein
to form stable and functional thick filament, changing
the shape of the heptad repeat motif.
Complexity of MYH7 differential diagnosis and the role of
muscle MRI
Considering this broad and overlapping spectrum of
clinical presentations, genetic analyses of MYH7-related
phenotypes can be difficult to target and it is not sur-
prising to have a delay in the conclusive diagnosis [28].
From our cohort, average time to diagnosis from onset
of symptoms was nearly 20 years and 10 patients were
identified only after of the study of numerous genes
associated with congenital myopathies. The typical pres-
entation of foot-drop in LDM can lead to an initial mis-
diagnosis of Hereditary Motor and Sensory Neuropathy,
as happened in the original Australian family [32]. How-
ever compensatory calf hypertrophy and severe weakness
of wrist and fingers extensor complete the phenotype.
These features can help in the differential diagnosis with
motor neuropathies (case 13) where both the anterior and
posterior compartment of leg are involved as well as in-
trinsic muscles of hands before flexors.
Muscle MRI of lower limbs in previously reported pa-
tients harboring mutations in MYH7 demonstrated a
typical pattern consisting in early and more severe in-
volvement of the tibialis anterior muscle, followed by ex-
tensor hallucis longus and extensor digitorum longus
muscles, whereas the lateral gastrocnemius muscle was
always spared [33, 34]. In the thighs, the vastus interme-
dius and lateralis were the most affected muscles;
followed by the biceps femoris and semimembranosus
muscles, whereas the rectus femoris, adductor longus,
semitendinosus, and gracilis muscles were usually spared
(Additional file 4: Figure S9) [3]. Slightly different from
previous reports, we noticed quite an earlier involve-
ment also of vastus medialis and sartorius, whereas vas-
tus intermedius, semimebranosus and biceps femoris
were affected later. Interestingly, a progression in the
muscle MRI pattern can be drawn from an initial substi-
tution of antero-medial muscles (Fig. 4), followed by the
involvement of postero-lateral muscles.
More relevant MRI finding in the 13 patients from our
study corroborated the notion that early involvement of
the tibialis anterior muscle can be considered the “red
flag” of a myosinopathy, also in patients with atypical
features, with a pattern of involvement that reflects the
clinical progression from distal to proximal muscle
weakness.
However, considering the wide phenotypic spectrum
related to MYH7-myopathyes, a distinction from other
congenital myopathies with distal affection is essential.
Particularly a predominant anterior lower leg involve-
ment is always presents in NEB-myopathies and in
ACTA1-myopathies with tibialis anterior involved first
[35], but the different histological framework at muscle
biopsy and the prevalent involvement at thigh level of
posterior compartment in ACTA1 and NEB mutations,
comparing with the prevalent involvement of vasti mus-
cles in myosinopathies could direct genetic tests. On the
other and, in cases of MYH-7 mutations and predomin-
ant proximal or axial weakness the striking affection of
tibialis anterior compared to thigh involvement is
strongly suggestive. Finally, few patients in our cohort
were first diagnosed as neuronopathies; also in these
cases muscle MRI can play an important role in differen-
tial diagnosis considering the striking differences of the
pattern of muscles involvement. In patients with distal
spinal muscular atrophy (or SMALED), in fact, there is
the prevalent involvement of thigh muscles with sparing
or hypertrophy of adductor longus and tibialis anterior
(i.e. DYNC1H1 mutated patients) or of biceps femorii
and medial gastrocnemius (i.e. TRPV4 mutated patients)
[36] differently from those described in MYH-7 related
myopathies.
Conclusion
To sum up, this study describes a cohort of 21 Italian
patients carrying a total of 14 different mutations in
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MYH7 and displaying a broad spectrum of clinical
presentations, such as different disease onset, muscle
weakness distribution, and the co-occurrence of heart
involvement. Under this blurred clinical-genetic sce-
nario, we foresee three forms of MYH7-myopathies: 1)
an early onset distal myopathy with cores, 2) a late onset
form of distal myopathy without histological evidence of
cores and with variable association of cardiomyopathy
and/or FTD and 3) the least frequent form of limb girdle
involvement with myofibrillar damage resembling the
myosin storage myopathy. We confirm that sites of mu-
tations do not correlate with severity and cannot predict
phenotype. This is particularly true for cardiomyopathies
which appear to be most common in men irrespective of
genotype and unrelated to mutations falling in specific
domains. Functional studies and more extensive molecu-
lar analyses are warrant to explore these aspects.
Unlikely the other, more frequent forms of congenital
myopathy, our findings also propose a progressive nature
of MYH7-related myopathies, and a striking difficulty in
targeting the underlying molecular etiology. Thus, NGS
tools such as MotorPlex can be dually useful to pinpoint
the MYH7 mutations in unspecific cases and to identify
associated alterations in additional muscular genes that
could act as modifiers and provide an explanation for
different phenotype.
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Additional file 1: Table S2. Histopathological findings. FTD fibre type
disproportion. (DOCX 20 kb)
Additional file 2: Figure S8. Details of muscle biopsy from case 4,
taken at 7 years old. A NADH staining (40x) from a longitudinal section
showing the extent of minicores along the fibres in the subsarcolemmal
area and diffuse in the sarcoplasm. B Electron microscopy images (7000x)
from the same biopsy, showed few normal sarcomeres with regular
alignment near a sharply demarcated core areas with myofibrillar
disorganization and sarcomeres disruption. (TIF 1388 kb)
Additional file 3: Table S3. Muscle MRI findings. AL: adductor longus;
AM: adductor magnus; G: gracilis; GM: gastrocnemius medialis; PG:
peroneal group; RF: rectus femoris; S: Sartorius; SO: soleus; TA: tibialis
anterior; VL: vastus lateralis; VM: vastus medialis; VI: vastus intermedius; BF:
biceps femoris; SM: semimembranousus. lc/bc: capus longus and brevis
of biceps femori Mod: moderate, Net: no sign of infiltration/fat
substitution (DOCX 23 kb)
Additional file 4: Figure S9. Schematic representation of muscle
involvement in MYH7 patients. In dark grey are the most affected
muscles, in light grey the muscle which are still affected but to a lesser
extent. In white are the spared muscles. AL: adductor longus; AM:
adductor magnus; G: gracilis; GM: gastrocnemius medialis; PG: peroneal
group; RF: rectus femoris; S: Sartorius; SO: soleus; TA: tibialis anterior; VL:
vastus lateralis; VM: vastus medialis; VI: vastus intermedius; BF: biceps
femoris; SM: semimembranousus. (TIF 270 kb)
Additional file 5: Table S4. Type and site of mutations and previous
literature reports. LMM ligh meromyosin domain. DM distal myopathy.
LDM Laing distal myopathy. CM congenital myopathy. CMP
cardiomyopathy. LVNC left ventricule non compacted. FTD fibre type
disproportion [37]. (DOCX 22 kb)
Additional file 6: Figure S7. Results of mRNA analysis on patients 7
and 18. PCR reactions, performed using cDNA synthesized from muscle
total RNA of patients 7 (c.5655 + 1G > A) and 18 (c.5655G > A), result into
an additional short fragment, because of an abnormal splicing. The
sequences of the normal size fragment showed the normal exon37-
exon38 boundary; electropherograms of the short fragment show the
skipping of exon38 and the exon37-exon39 junction. Red circles indicate
the genomic position of the mutated nucleotides. (JPG 514 kb)
Additional file 7: Figure S6. COILS prediction of the effect of mutations
in the LMM region on the probability of the myosin tails forming a coiled
coil. COILS analysis of residues 1193-1805, using a MTIDK matrix and
scanning windows of 14 (green line), 21 (blu line) and 28 (red line) amino
acids, shows that all the 4 novel distal-myopathy mutations (p.Ser1435Pro,
p.Ala1439Pro, p.Ala1603Pro and Glu1619Lys) impact the ability of the
myosin tail to form a coiled coil (or hamper a coiled-coil conformation).
Arrow indicates the position of the mutated amino acids. (JPG 183 kb)
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